This effect on gastric emptying, coupled with its action on GLP-1R in the hypothalamus—an area of the brain that regulates hunger and satiety—results in reduced food intake, making GLP-1 an important factor in weight management and obesity treatment [44,45]. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.